Evaluation of Guillain-Barre Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

被引:43
作者
Burwen, Dale R. [1 ]
Ball, Robert [1 ]
Bryan, Wilson W. [2 ]
Izurieta, Hector S. [1 ]
La Voie, Lawrence [5 ,6 ]
Gibbs, Neville A. [2 ]
Kliman, Rebecca [3 ,4 ]
Braun, M. Miles [1 ]
机构
[1] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA
[2] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] Ctr Medicare, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[4] Ctr Medicaid Serv, Qual Improvement Grp, Off Clin Stand & Qual, Baltimore, MD USA
[5] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
[6] Ctr Medicare, Kansas City Reg Off, Kansas City, MO USA
关键词
UNITED-STATES; ASSOCIATION; IMMUNIZATION; SURVEILLANCE; FEATURES; CRITERIA; SAFETY; SWEDEN;
D O I
10.1016/j.amepre.2010.05.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The 1976-1977 swine influenza vaccine was associated with an elevated risk of Guillain-Barre Syndrome (GBS), especially within 6 weeks after vaccination. A 2004 IOM report concluded that evidence was inadequate to accept or reject a causal relationship between subsequent influenza vaccine formulations and GBS. Studies published after the IOM report have been limited by passively reported data or lack of validation of coded diagnoses. Purpose: To evaluate whether influenza vaccine is associated with GBS. Methods: Controlled observational study using national data from the Medicare program, which ensures a predominantly elderly population. People included had a Medicare claim for influenza vaccination during September-December in 2000 or 2001. Medical records were reviewed to classify definite, probable, or possible GBS (or not a case) using a standardized case definition. In a risk interval design, the incidence rate of GBS during Weeks 0-6 after vaccination (exposed period) was compared to Weeks 9-14 after vaccination (comparison period). Data collection occurred during 2003-2007, and analysis was conducted during 2007-2009. Results: Primary analysis included 22.2 million vaccinees, among whom 164 definite or probable GBS cases with onset during Weeks 0-6 or 9-14 were identified. The incidence rate ratio (IRR [95% CIs]) based on the GBS rate in the vaccine-exposed versus comparison periods, was 1.04 (0.76, 1.43) for combined years; 0.86 (0.52, 1.41) among people vaccinated in 2000; and 1.21 (0.79, 1.86) among people vaccinated in 2001. Secondary analysis additionally included 74 possible GBS cases; results were similar. Conclusions: Overall, the results do not support an association between influenza vaccine receipt and GBS among the elderly for the years studied (2000-2001 and 2001-2002 formulations). (Am J Prev Med 2010;39(4):296-304) Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine
引用
收藏
页码:296 / 304
页数:9
相关论文
共 40 条
[1]  
Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]   ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].
ASBURY, AK ;
CORNBLATH, DR .
ANNALS OF NEUROLOGY, 1990, 27 :S21-S24
[4]   Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996 [J].
Bogliun, G ;
Beghi, E .
ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (02) :100-106
[5]   Evaluating adverse events after vaccination in the Medicare population [J].
Burwen, Dale R. ;
La Voie, Lawrence ;
Braun, M. Miles ;
Houck, Peter ;
Ball, Robert .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) :753-761
[6]  
*CDC, 2001, MMWR-MORBID MORTAL W, V50, P466
[7]  
*CDC, 2001, MMWR-MORBID MORTAL W, V50, P5
[8]  
*CDC, 2008, MMWR-MORBID MORTAL W, V57, P25
[9]   Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States [J].
Chen, RT ;
Glasser, JW ;
Rhodes, PH ;
Davis, RL ;
Barlow, WE ;
Thompson, RS ;
Mullooly, JP ;
Black, SB ;
Shinefield, HR ;
Vadheim, CM ;
Marcy, SM ;
Ward, JI ;
Wise, RP ;
Wassilak, SG ;
Hadler, SC ;
Swint, E ;
Hardy, JR ;
Payne, T ;
Immanuel, V ;
Benson, P ;
Draket, J ;
Drew, L ;
Mendius, B ;
Ray, P ;
Lewis, N ;
Fireman, BH ;
Jing, J ;
Wulfsohn, M ;
Lugg, MM ;
Osborne, P ;
Rastogi, S ;
Patriarca, P ;
Caserta, V .
PEDIATRICS, 1997, 99 (06) :765-773
[10]   Epidemiological surveillance of Guillain-Barre syndrome in Sweden, 1996-1997 [J].
Cheng, Q ;
Jiang, GX ;
Fredrikson, S ;
Link, H ;
de Pedro-Cuesta, J .
ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (02) :104-110